ÃÜÌÒAV: Formulating Life-Enhancing Solutions for Healthcare
- Proven high-performance materials and applications on display at MD&M West 2025
- From hospitals to homes, versatile materials support the development of devices essential for medical professionals and patients alike
From packaging to drug delivery, diagnostic, wearable devices and more, material solutions from ÃÜÌÒAV are essential to a wide range of life-enhancing and life-saving healthcare applications. ÃÜÌÒAV will highlight these solutions for healthcare and life science applications at booth #2439 at , February 4-6 in Anaheim, Calif.
Booth visitors can discover the latest innovations enabled by ÃÜÌÒAV materials:
- MoMe ARC? system: This remote cardiac monitoring device features Makrolon? 2458 polycarbonate from ÃÜÌÒAV. This material provides durability, biocompatibility, and aesthetic quality, enhancing the device's performance and user experience.
- CQ Portfolio: A showcase of low carbon footprint solutions from ÃÜÌÒAV, including a mono-material drug delivery demonstrator device that highlights simplified recycling by eliminating the need to sort different types of plastics as well as demonstrates the possibility of using regrind for the manufacture of new devices in the electronics industry.
- : A functional pulse oximeter showcases TPU film as a robust, durable and reliable substrate, offering excellent stretchability and conformability for printed electronics in wearables.
A variety of the company¡¯s advanced materials can be experienced firsthand, including:
- Polycarbonate resins and blends: ÃÜÌÒAV¡¯s medical grade materials including, Makrolon?, Bayblend?, Apec? and Makroblend? deliver exceptional strength and durability for many applications, and have been used in drug delivery devices, respiratory applications, medical device housings and more.
- Polyurethane raw materials and adhesives: Baymedix? polyurethane adhesive and foam components offer excellent breathability, excellent absorption and low trauma removal. For wearable applications, ÃÜÌÒAV offers skin-friendly adhesives and thermoformable foams for electronic embedding.
- Thermoplastic Polyurethane (TPU) resins: Texin? Rx TPU resins offer flexibility and strength, which are required for applications such as medical tubing and dental applications, resistant to cleaning agents and bacteria.
- Films: Dureflex? and Platilon? TPU films are breathable, elastic, and skin-friendly for wound care, smart patches, and wearables. Bayfol? TPU/PETG bi-layer films and Makrofol? PC films are utilized in medical packaging, with Makrofol? PC also offering excellent performance in steam sterilization.
MD&M West attendees can stop by the ÃÜÌÒAV booth (#2439) to explore how the company¡¯s materials are transforming healthcare applications.
About ÃÜÌÒAV:
ÃÜÌÒAV is one of the world¡¯s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. ÃÜÌÒAV supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from ÃÜÌÒAV are also used in sectors such as sports and leisure, telecommunications and health, as well as in the chemical industry itself.
The company is geared completely to the circular economy. In addition, ÃÜÌÒAV aims to achieve climate neutrality for its Scope 1 and Scope 2 emissions by 2035, and the Group¡¯s Scope 3 emissions are also set to be climate neutral by 2050. ÃÜÌÒAV generated sales of EUR 14.2 billion in fiscal year 2024. At the end of 2024, the company had 46 production sites worldwide and employed approximately 17,500 people (calculated as full-time equivalents).
Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by ÃÜÌÒAV. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in ÃÜÌÒAV¡¯s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.